Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VVZ-2471 by Vivozon for Neuropathic Pain (Neuralgia): Likelihood of Approval
VVZ-2471 is under clinical development by Vivozon and currently in Phase I for Neuropathic Pain (Neuralgia). According to GlobalData, Phase...
VVZ-2471 by Vivozon for Anxiety Disorders: Likelihood of Approval
VVZ-2471 is under clinical development by Vivozon and currently in Phase I for Anxiety Disorders. According to GlobalData, Phase I...
VVZ-2471 by Vivozon for Depression: Likelihood of Approval
VVZ-2471 is under clinical development by Vivozon and currently in Phase I for Depression. According to GlobalData, Phase I drugs...
VVZ-2471 by Vivozon for Opium (Opioid) Addiction: Likelihood of Approval
VVZ-2471 is under clinical development by Vivozon and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData, Phase...